SEC Form 4 · accession 0001144204-17-062469
Ensysce Biosciences, Inc. · ENSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Carrera
Officer — Senior Vice President
Period of report
Dec 5, 2017
Accepted (ET)
Dec 5, 2017 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 5, 2017 | J | 1,465 | $0.00 | D | 63,031 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As contemplated by the securities subscription agreement between the reporting person and the Company, 1,465 shares held by Mr. Carrera were forfeited upon consummation of the Company's initial public offering for no consideration.
- F2Includes an aggregate of 8,330 shares held by Mr. Carrera that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not fully exercised.